VoltaGrid Closes $5.0 Billion Comprehensive Financing Package Consisting of $2.0 Billion of Senior Secured Second Lien Notes and $3.0 Billion Asset-Based Loan Facility
Notified -
Globe Newswire10-11-2025, 20:00
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T 31-05-2025, 08:00
